CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 394 enrolled
Drug / intervention
MADIT-CRT ICD +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01294449
NCT01294449N/ACompleted
CompareCT.gov

Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Post Approval Registry

Boston Scientific Corporation·observational·Posted Feb 11, 2011·Updated Dec 4, 2014

In Brief

An observational study evaluating MADIT-CRT ICD and MADIT-CRT CRT-D for Heart Failure. Completed, enrolled 394 participants across 1 site.

Detailed Summary

MADIT-CRT PAR is an FDA mandated follow-up registry for patients that participated in the MADIT-CRT IDE study examining long-term mortality. (MADIT-CRT IDE: NCT00180271)

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 11, 2011
Enrollment StartMar 1, 2011
Primary CompletionOct 1, 2013
Study CompletionNov 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 15.4 years ago

Interventions

MADIT-CRT ICDdevice

Patients that were randomized to the the implantable cardioverter defibrillator (ICD) device for the study.

MADIT-CRT CRT-Ddevice

Patients that were randomized to the the cardiac resynchronization therapy with defibrillation (CRT-D) device for the study.